Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A - Wikidata - wikimedia - TriplyDB

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

http://www.wikidata.org/entity/Q27640215

about

Bacteria and cancer: cause, coincidence or cure? A review The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects Study of Coxsackie B viruses interactions with Coxsackie Adenovirus receptor and Decay-Accelerating Factor using Human CaCo-2 cell line Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.Solution structure of a functionally active fragment of decay-accelerating factor The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55)Complement regulation at the molecular level: The structure of decay-accelerating factor Interaction of Decay-Accelerating Factor with Coxsackievirus B3 Interaction of Decay-Accelerating Factor with Echovirus 7 The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus Surface Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.Complement Evasion Strategies of Viruses: An Overview.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration.Hepatitis C virus infection: establishment of chronicity and liver disease progression Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids Human diffusely adhering Escherichia coli expressing Afa/Dr adhesins that use human CD55 (decay-accelerating factor) as a receptor does not bind the rodent and pig analogues of CD55 Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode.Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus.Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.Investigating the structure of the factor B vWF-A domain/CD55 protein-protein complex using DEER spectroscopy: successes and pitfalls.Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces.The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).Structure-based Mapping of DAF Active Site Residues That Accelerate the Decay of C3 Convertases

P2860

Q21245476-9D2D8080-7243-478B-AECB-805F0F28B111 Q21245477-6DE10296-BDF2-4385-A691-B18D4C5D2DF0 Q21284422-1FD657E4-05C3-4CE2-A906-60F7A9D16630 Q24533362-C2E1CEFF-0EEE-4B90-BAC2-A330D60AD31D Q27640881-53541663-66FC-4BC2-B781-19AC36232287 Q27642610-4D5B9CDB-AA16-4B8E-AAA7-38EA92005BC5 Q27643002-B433B0FF-6B17-4D7B-8F7D-D10E71E59ACE Q27647885-F2729C50-F751-44EC-8D63-DF3D881CA8FE Q27664791-C2B6D76D-980C-4E3A-8861-AAE63883BDBA Q27673022-DA71E391-11CB-4694-AF10-B4000E7CB4C4 Q33755215-3BF605F9-1FC5-40DC-9F6A-EDAE415F8573 Q33780553-5B4A203B-EB8B-473F-931E-50DC231D9890 Q33804431-0CC5E6FD-5ED6-4AD7-89CF-67C036B4F552 Q34297628-6317D51A-B21C-4660-A2DD-519A1BD12BC4 Q34662323-73D81960-EBFD-43EA-9E02-CD691BDEDB20 Q35728873-9A564F38-A4B0-41A4-9ACE-5B5F932E5AAE Q36093715-3E5A4669-C58C-4A1A-87DC-2592AF328E15 Q36443855-4D2F3736-5B2C-4904-B9B8-ABC779071F62 Q36906411-E1633AC7-3600-4BC5-99FF-0C33DFA2ED91 Q38315657-8C71AF76-2666-4D54-B8E0-7386EBC8DF0B Q39644772-E45002AA-ADD2-4119-9010-BFF684244AA1 Q40354189-5F5A2E76-48C1-4304-BAD6-6DAAC1074B07 Q40625728-B10F0ECE-5A4C-4533-95A1-41AE0A00FA4B Q40682669-A4C8F92D-210A-4A7D-8715-1AC7B791B367 Q43095136-DFAB1D4D-503A-46B1-B774-9E5E010BD795 Q43105299-B9BAB835-BD84-4147-9CB2-9142F7B8FA5C Q45013859-80238ECF-C87E-43D2-8804-70A992182D02 Q45145763-807E75BC-563F-4D95-A79E-6B5761AA94D0 Q58210854-983236BB-D846-4F61-A672-209382F30A6C

P2860

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

http://www.wikidata.org/entity/Q27640215

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@ast

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@en

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@nl

type

label

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@ast

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@en

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@nl

prefLabel

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@ast

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@en

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@nl

P1433

Q27640215-7FC37877-F5B0-4459-87AA-F2989B8D7229

P1476

Q27640215-C2E612D1-7607-47A6-A031-CB2E3CEE81C0

P2093

Q27640215-7D56C7D0-129B-46A5-BC05-154A6E6A955D

Q27640215-83956D38-C115-400D-B304-08C004168EDF

Q27640215-BE28608E-4F0E-4189-BA70-EED540A721DD

Q27640215-C03D18CD-6D6D-48AD-857A-16E4F0624801

Q27640215-E6D746DD-DEB6-45C3-B654-FF0207A0DF0D

P2860

Q27640215-0A8D94AD-E09B-4D95-B228-DBDA5757CE20

Q27640215-1E97004D-4263-4F35-8E6E-8BC86F96C9AC

Q27640215-240466C0-9698-43A2-8F3C-CA6756E609CC

Q27640215-29651A4F-AA1F-4642-9225-C481519BBE99

Q27640215-2F1B75AA-BF8B-477A-B419-58E7DAC2CC05

Q27640215-38E3681F-8A09-43F1-8C11-11D4BE5F0417

Q27640215-41A48528-EA51-41D4-A9C6-701D33B0A332

Q27640215-452D70A3-C4C5-46A8-81C3-A9149564CF88

Q27640215-5D675652-BCB9-42E7-9C44-351268DC293B

Q27640215-6624E995-62AA-4D23-9A06-773F74DB2420

P304

Q27640215-C294CB8E-B942-4AB4-A35A-1ECBF6CA723C

P31

Q27640215-74EC14FA-51F6-438E-8FB4-5FB2237B0002

P3181

Q27640215-5C8B7273-5749-421D-A130-B1382EEFF67B

P356

Q27640215-9506341D-07F2-4026-B9DD-5F77699E00BF

P407

Q27640215-D5A50104-8230-46F7-AFA9-093CD9AE1F55

P433

Q27640215-93741F43-D42D-4DA1-B9DD-791B7DB6AEB8

P478

Q27640215-AB9B86D9-4BF4-44CB-9617-FDE2EE5076B8

P50

Q27640215-6BC0F2EC-BDE5-4F55-93FB-AEC474BF9516

Q27640215-6F2E85C1-D862-4E18-8385-3B56D6D07CB4

Q27640215-C22028F7-0F1C-4235-B6FB-8DD90413F911

P577

Q27640215-8137D8DC-75BB-4631-BB9F-F6D388CE67B1

P698

Q27640215-C84A7BBC-D8C9-4E34-81C5-C657EA23EEB3

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

@en

P2093

David J Evans

http://www.w3.org/2001/XMLSchema#string

Jason Billington

http://www.w3.org/2001/XMLSchema#string

O Brad Spiller

http://www.w3.org/2001/XMLSchema#string

Pamela Williams

http://www.w3.org/2001/XMLSchema#string

Robert Powell

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA

The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Three-dimensional structure of a complement control protein module in solution

Solution structure of a pair of complement modules by nuclear magnetic resonance

XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density

The CCP4 suite: programs for protein crystallography

Structure/function studies of human decay-accelerating factor

P304

10691-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4328405

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M212561200

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

278

http://www.w3.org/2001/XMLSchema#string

P50

Yasmin Chaudhry

P577

2003-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12499389

http://www.w3.org/2001/XMLSchema#string